These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37421458)

  • 1. A novel pyroptosis-related signature predicts prognosis and indicates immunotherapy in oral squamous cell carcinoma.
    Gao Y; Zhang X; Li Y; Gao J; Liu S; Cai H; Zhang J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12057-12070. PubMed ID: 37421458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis.
    Qi L; Tang Z
    Sci Rep; 2024 Mar; 14(1):6149. PubMed ID: 38480853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma.
    Liang S; Ji L; Yu Z; Cheng Y; Gao R; Yan W; Zhang F
    Hereditas; 2024 Feb; 161(1):10. PubMed ID: 38414024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of pyroptosis regulation patterns and their influence on tumor immune microenvironment and patient prognosis in glioma.
    Fan T; Wan Y; Niu D; Wang B; Zhang B; Zhang Z; Zhang Y; Gong Z; Zhang L
    Discov Oncol; 2022 Mar; 13(1):13. PubMed ID: 35274175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
    Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
    Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma.
    Gong H; Liu Z; Yuan C; Luo Y; Chen Y; Zhang J; Cui Y; Zeng B; Liu J; Li H; Deng Z
    Comput Biol Med; 2024 Mar; 171():108198. PubMed ID: 38417385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
    BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
    Li Z; Shen L; Li Y; Shen L; Li N
    Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of prognostic signature of patients with oral squamous cell carcinoma based on pyroptosis-related long non-coding RNAs.
    Xin Y; Zhang J; Jiang Q; Qiu J
    Front Surg; 2022; 9():935765. PubMed ID: 36211292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
    Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
    World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma.
    Cui Y; Cheng Y; Huang W; Liu J; Zhang X; Bu M; Li X
    Arch Oral Biol; 2023 Aug; 152():105719. PubMed ID: 37178584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immune cell infiltration landscape classification to predict prognosis and immunotherapy effect in oral squamous cell carcinoma.
    Yang Z; He F
    Comput Methods Biomech Biomed Engin; 2024; 27(2):191-203. PubMed ID: 36794748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma.
    Shen T; Zhang J; Wang Y; Liu B
    J Immunol Res; 2022; 2022():8443392. PubMed ID: 35733916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.
    Xu Z; Li X; Pan L; Tan R; Ji P; Tang H
    J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
    Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
    BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.